癲癇設備市場規模、佔有率和成長分析：按產品類型、最終用戶、地區分類 - 產業預測，2024-2031 年

2022年癲癇設備市場規模為13億美元，從2023年的14.2億美元成長到2031年的28.7億美元，預計複合年成長率為9.2%。

由於癲癇盛行率的增加、意識的提高以及醫療技術的進步等因素，癲癇設備市場正在顯著成長。對植入式神經刺激設備和穿戴式癲癇監測設備等癲癇設備的需求不斷成長，以改善癲癇發作的檢測、管理和患者預後。然而，高成本、有限的報銷政策以及對熟練專業人員的需求等挑戰阻礙了市場的擴張。北美目前領先市場，但由於醫療基礎設施的改善和癲癇管理意識的提高，亞太地區正在經歷顯著成長。主要趨勢包括增加設備技術創新以及強調以患者為中心的解決方案。

目錄

介紹

• 這項研究的目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 市場生態系統
• 專利分析
• 監管環境
• 創新矩陣
• 主要投資分析
• 關鍵成功因素
• 市場魅力指數
• 競爭程度

癲癇設備市場：依產品類型

• 市場概況
• 常規裝置
  • 監控裝置
  • 腦電圖儀
  • 標準腦電圖設備
  • 視訊腦電圖設備
  • 其他/攜帶式腦電圖設備
  • 肌電圖儀
  • 腦磁圖裝置
  • 其他
• 腦深部電刺激裝置
• 穿戴式裝置

癲癇設備市場：依最終用戶分類

• 市場概況
• 醫院
• 門診手術中心
• 專科診所
• 居家醫療
• 診斷中心

癲癇設備市場：按地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Medtronic plc（Ireland）
• Abbott Laboratories（United States）
• LivaNova PLC（United Kingdom）
• NeuroPace, Inc.（United States）
• Cyberonics, Inc.（United States）
• Nihon Kohden Corporation（Japan）
• Biotronik SE & Co. KG（Germany）
• Boston Scientific Corporation（United States）
• Elekta AB（Sweden）
• Natus Medical Incorporated（United States）
• NeuroSigma, Inc.（United States）
• Philips Healthcare（Netherlands）
• Magstim Company Limited（United Kingdom）
• BrainScope Company, Inc.（United States）
• Imec（Belgium）
• Jordan NeuroScience, Inc.（United States）
• Masimo Corporation（United States）
• Neuronetics, Inc.（United States）
• Nexstim Plc（Finland）
• Cadwell Industries, Inc.（United States）

Epilepsy Devices Market size was valued at USD 1.30 billion in 2022 and is poised to grow from USD 1.42 billion in 2023 to USD 2.87 billion by 2031, growing at a CAGR of 9.2% during the forecast period (2024-2031).

The Epilepsy Devices Market is seeing substantial growth driven by factors such as increasing incidence of epilepsy, heightened awareness, and advancements in medical technology. There is a rising demand for epilepsy devices, including implantable neurostimulators and wearable seizure monitoring devices, aimed at improving seizure detection, management, and patient outcomes. However, challenges such as high costs, limited reimbursement policies, and the requirement for skilled professionals hinder market expansion. North America currently leads the market, while the Asia-Pacific region is experiencing significant growth due to improving healthcare infrastructure and rising awareness about epilepsy management. Key trends include ongoing innovation in device technology and a focus on patient-centered solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Epilepsy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Epilepsy Devices Market Segmental Analysis

The global epilepsy devices market is segmented based on product type, end-users, and region. Based on product type, the market is segmented into Conventional Devices (Monitoring Devices [EEG devices {Standard EEG devices, Video EEG devices, Other/Ambulatory EEG devices}, EMG devices, MEG devices, other monitoring devices], Deep Brain Stimulation Devices), and wearable devices. Based on End-users, the market is segmented into, Hospitals, Neurology Centers, Ambulatory Surgery Centers & Clinics, Diagnostic Centers, Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.

Drivers of the Epilepsy Devices Market

The rising global prevalence of epilepsy has significantly expanded the population in need of advanced medical treatments, driving demand for innovative interventions. Technological progress in epilepsy devices, such as implantable neurostimulators and responsive neurostimulation, has enhanced seizure management and improved patient outcomes. Additionally, increasing awareness of epilepsy and the significance of early diagnosis and intervention have positively influenced market dynamics.

Restraints in the Epilepsy Devices Market

One of the main challenges in the market is the high cost of advanced epilepsy devices, limiting their accessibility for a significant portion of the population, especially in regions with limited healthcare resources. Additionally, reimbursement policies and insurance coverage can also hinder widespread adoption. Another constraint is the requirement for skilled professionals to properly implement and monitor these devices, underscoring the importance of comprehensive healthcare infrastructure.

Market Trends of the Epilepsy Devices Market

There is a growing focus on wearable seizure monitoring devices, indicating a trend towards patient-centered and non-invasive solutions for continuous monitoring. Additionally, there is increasing attention on responsive neurostimulation technologies, which offer adaptive responses in real-time to abnormal brain activity detected. Personalized medicine is emerging as a significant trend, with an emphasis on customizing treatment approaches according to individual patient profiles.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Ecosystem of the Market
• Patent Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Market Attractive Index
• Degree of Competition

Epilepsy Devices Market by Product Type

• Market Overview
• Conventional Devices
  • Monitoring Devices
  • EEG devices
  • Standard EEG devices
  • Video EEG devices
  • Other/Ambulatory EEG devices
  • EMG devices
  • MEG devices
  • Other monitoring devices
• Deep Brain Stimulation Devices
• Wearable Devices

Epilepsy Devices Market by End User

• Market Overview
• Hospitals
• Ambulatory Surgical Centres
• Specialty Clinics
• Home Care Settings
• Diagnostic Centres

Epilepsy Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyberonics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Magstim Company Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BrainScope Company, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imec (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jordan NeuroScience, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuronetics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexstim Plc (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadwell Industries, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments